László Nagy from the HUN-REN BRC Szeged elected as EMBO member

2024. júl. 9. | News

This year, the EMBO (European Molecular Biology Organization), founded on 12 July 1964, celebrates its 60th anniversary and its membership today counts more than 2100 researchers in the field of life sciences, 92 of whom have been awarded Nobel Prizes.

Researchers at HUN-REN BRC Szeged have developed microrobots capable of capturing cells

2024. jún. 28. | News

Single-cell investigation methods such as single-cell genetics, proteomics or imaging-based morphological classification have risen to the forefront of biological research in the last decade.

New Targets to Enhance the Effectiveness of PARP Inhibitors in Cancer Research

2024. jún. 14. | News

The ultimate goal of cancer therapy is to eliminate malignant cells with minimal side effects. Modern approaches increasingly focus on targeting specific molecular pathways critical for tumor survival and proliferation, rather than relying on traditional cytotoxic agents that kill cells indiscriminately.

Three HUN-REN BRC Szeged researchers won the János Bolyai Research Scholarship

2024. jún. 13. | News

On 12 June 2024, the Hungarian Academy of Sciences (HAS) published the list of this year's winners of the János Bolyai Research Scholarship. The Bolyai Scholarship was established in 1997 "to encourage and recognise outstanding research and development achievements". Researchers under 45 years of age could apply for the 250.000Ft monthly grant for a period of 1, 2 or 3 years.

A journey to your (immune) self

2024. máj. 14. | News

Essentially, the immune system's primary function is to differentiate between our own harmless molecules and potentially harmful foreign ones. This distinction is largely influenced by the degree of similarity a molecule bears to those the immune system is exposed to early in life.

Straub-Days 2024

2024. máj. 10. | News

On May 30 and 31, 2024, the "Straub-Days" of the HUN-REN Biological Research Centre, Szeged (HUN-REN BRC Szeged) will take place in the institute building in Temesvári körút. The event is organized by the HUN-REN BRC Szeged and the Hungarian Centre of Excellence of Molecular Medicine (HCEMM). The organizers welcome all interested parties.

Bálint Kintses Receives Szent-Györgyi Talent Award for Antibiotic Resistance Research

2024. ápr. 22. | News

This year, Bálint Kintses, leader of the Translational Microbiology Laboratory at the BRC was honored for his innovative work on antibiotic resistance, published in Nature Microbiology.


 

New discovery sheds light on the survival strategy of Antarctic bacteria

2024. febr. 23. | News

The overwhelming majority of our biological knowledge stems from the study of organisms found in our immediate surroundings or from within our own bodies. This holds true for bacteria as well, as the most well-studied species are from environments inhabited by humans or from within the human body itself. However, there are numerous conditions where the majority of these species are unable to survive but other bacteria are able to survive and even thrive. One such example are species belonging to the genus Psychrobacter, which can be found living in the icy terrain of Antarctica.

BRC Researchers participate in a Horizon Europe consortium unraveling the interplay between infectious diseases and noncommunicable diseases

2024. jan. 22. | News

The Systems Immunology Research Group at HUN-REN Biological Research Centre, Szeged led by Máté Manczinger is participating in a HORIZON-HEALTH-2023-DISEASE-03 project named ID-DarkMatter-NCD.

As part of the Algae4IBD research project, Bettina Ughy and her colleagues are investigating the applicability of algae in the treatment of IBD

2024. jan. 18. | News

The Algae4IBD project (https://algae4ibd.eu/) brings together 21 researcher institutes and companies from 11 countries to unify their expertise in different fields to help patients with chronic inflammatory bowel disease (IBD). Chronic inflammation of the digestive tract is a very complex disease for which there is no universally applicable treatment. Since algae are known to produce specific bioactive molecules, they are a promising source when looking for new therapeutic agents.